Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 941,243
  • Shares Outstanding, K 759,067
  • Annual Sales, $ 606,880 K
  • Annual Income, $ -225,680 K
  • EBIT $ -40 M
  • EBITDA $ 57 M
  • 60-Month Beta 1.49
  • Price/Sales 1.51
  • Price/Cash Flow N/A
  • Price/Book 0.72

Options Overview Details

View History
  • Implied Volatility 261.14% (+152.33%)
  • Historical Volatility 36.14%
  • IV Percentile 92%
  • IV Rank 31.46%
  • IV High 713.69% on 03/11/26
  • IV Low 53.43% on 08/22/25
  • Expected Move (DTE 24) 0.0425 (3.48%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 3,214
  • Volume Avg (30-Day) 917
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 28,750
  • Open Int (30-Day) 27,546
  • Expected Range 1.1775 to 1.2625

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 5
  • High Estimate $-0.05
  • Low Estimate $-0.08
  • Prior Year $-0.10
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0950 +11.42%
on 03/30/26
1.2500 -2.40%
on 04/17/26
+0.1000 (+8.93%)
since 03/20/26
3-Month
1.0950 +11.42%
on 03/30/26
1.4300 -14.69%
on 01/22/26
-0.0700 (-5.43%)
since 01/20/26
52-Week
1.0950 +11.42%
on 03/30/26
1.6000 -23.75%
on 10/06/25
-0.2000 (-14.08%)
since 04/17/25

Most Recent Stories

More News
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that the first participants have been dosed in a Phase 1 clinical trial...

OPK : 1.2200 (-1.61%)
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11,...

OPK : 1.2200 (-1.61%)
OPKO Health: Q4 Earnings Snapshot

OPKO Health: Q4 Earnings Snapshot

OPK : 1.2200 (-1.61%)
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces...

OPK : 1.2200 (-1.61%)
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the...

OPK : 1.2200 (-1.61%)
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

This is the third  program that s uccessfully combine s Entera’s oral peptide N- Tab ® platform with OPKO ’s advanced protein chemistry capabilities The c ompanies have...

OPK : 1.2200 (-1.61%)
ENTX : 1.3400 (+4.69%)
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK ) announced today that management will be participating in the 44 th Annual J.P. Morgan Healthcare Conference, being held January...

OPK : 1.2200 (-1.61%)
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37 th Annual Healthcare Conference, being held December...

OPK : 1.2200 (-1.61%)
NextPlat Reports Third Quarter 2025 Results

Company Reports $13.8M in Q3 Revenue as Refocusing and Cost Cutting Initiatives Drive Improved Late Quarter Performance with Accelerated Sequential Improvements Expected in Q4 and into 2026 

BABA : 140.17 (-0.60%)
NXPL : 5.87 (+7.90%)
NXPLW : 0.0078 (-35.00%)
OPK : 1.2200 (-1.61%)
OPKO Health: Q3 Earnings Snapshot

OPKO Health: Q3 Earnings Snapshot

OPK : 1.2200 (-1.61%)

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.2633
2nd Resistance Point 1.2467
1st Resistance Point 1.2333
Last Price 1.2200
1st Support Level 1.2033
2nd Support Level 1.1867
3rd Support Level 1.1733

See More

52-Week High 1.6000
Fibonacci 61.8% 1.4071
Fibonacci 50% 1.3475
Fibonacci 38.2% 1.2879
Last Price 1.2200
52-Week Low 1.0950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.